Week in review: Gene therapy for LCA, Susvimo voluntary recall, smoking accelerates RNFL thinning

An experimental gene therapy shows promise in Leber congenital amaurosis (LCA), Genentech issues a voluntary recall for Susvimo, and heavy smoking leads to increased RNFL thinning.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553